Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.2 | 2.26 |
NAV | ₹22.93 | ₹168.01 |
Fund Started | 16 Nov 2017 | 13 Oct 2005 |
Fund Size | ₹1287.96 Cr | ₹1374.33 Cr |
Exit Load | Exit load of 1%, if redeemed within 30 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -1.21% | 5.10% |
3 Year | 19.19% | 20.15% |
5 Year | 23.47% | 24.39% |
1 Year
3 Year
5 Year
Equity | 97.83% | 95.01% |
Cash | 2.17% | 4.99% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
HDFC Bank Ltd. | 9.75% |
Larsen & Toubro Ltd. | 8.24% |
ICICI Bank Ltd. | 7.33% |
Ambuja Cements Ltd. | 7.08% |
NTPC Ltd. | 6.34% |
State Bank of India | 6.10% |
Kalpataru Projects International Ltd. | 4.87% |
Tata Steel Ltd. | 4.64% |
Prestige Estates Projects Ltd. | 4.46% |
Ultratech Cement Ltd. | 4.27% |
Name | Assets |
|---|---|
Infosys Ltd. | 8.83% |
ICICI Bank Ltd. | 6.77% |
Reliance Industries Ltd. | 6.47% |
HDFC Bank Ltd. | 5.24% |
NTPC Ltd. | 4.83% |
Bharti Airtel Ltd. | 4.81% |
Larsen & Toubro Ltd. | 4.31% |
Sun Pharmaceutical Industries Ltd. | 3.59% |
Dr. Reddy's Laboratories Ltd. | 3.04% |
Tata Consultancy Services Ltd. | 2.94% |
Name | Dhruv Muchhal | Sri Sharma |
Start Date | 10 Sep 2025 | 30 Apr 2021 |
Name
Start Date
Description | The scheme aims to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of entities engaged in and/or expected to benefit from the growth in housing and its allied business activities. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 16 Nov 2017 | 13 Oct 2005 |
Description
Launch Date